» Articles » PMID: 18946483

Variation Within the CLEC16A Gene Shows Consistent Disease Association with Both Multiple Sclerosis and Type 1 Diabetes in Sardinia

Overview
Journal Genes Immun
Date 2008 Oct 24
PMID 18946483
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Variation within intron 19 of the CLEC16A (KIAA0350) gene region was recently found to be unequivocally associated with type 1 diabetes (T1D) in genome-wide association (GWA) studies in Northern European populations. A variant in intron 22 that is nearly independent of the intron 19 variant showed suggestive evidence of association with multiple sclerosis (MS). Here, we genotyped the rs725613 polymorphism, representative of the earlier reported associations with T1D within CLEC16A, in 1037 T1D cases, 1498 MS cases and 1706 matched controls, all from the founder, autoimmunity-prone Sardinian population. In these Sardinian samples, allele A of rs725613 is positively associated not only with T1D (odds ratio=1.15, P one-tail=5.1 x 10(-3)) but also, and with a comparable effect size, with MS (odds ratio=1.21, P one-tail 6.7 x 10(-5)). Taken together these data provide evidence of joint disease association in T1D and MS within CLEC16A and underline a shared disease pathway.

Citing Articles

Exploring proteomic immunoprofiles: common neurological and immunological pathways in multiple sclerosis and type 1 diabetes mellitus.

Cano-Cano F, Lara-Barea A, Cruz-Gomez A, Martin-Loro F, Gomez-Jaramillo L, Gonzalez-Montelongo M Mol Med. 2025; 31(1):36.

PMID: 39901093 PMC: 11789306. DOI: 10.1186/s10020-025-01084-x.


Whole-Genome Resequencing Reveals Signatures of Adaptive Evolution in and .

Yang J, Cai Z, Fang Y, Shan B, Zhang R, Lin L Animals (Basel). 2024; 14(16).

PMID: 39199873 PMC: 11350792. DOI: 10.3390/ani14162339.


Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma.

Li W, Yao R, Yu N, Zhang W Cancer Biomark. 2024; 40(1):125-139.

PMID: 38517778 PMC: 11191449. DOI: 10.3233/CBM-230325.


SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis.

Pandey R, Bakay M, Hakonarson H Front Immunol. 2023; 14:1271102.

PMID: 38022642 PMC: 10643230. DOI: 10.3389/fimmu.2023.1271102.


-An Emerging Master Regulator of Autoimmunity and Neurodegeneration.

Pandey R, Bakay M, Hakonarson H Int J Mol Sci. 2023; 24(9).

PMID: 37175930 PMC: 10179542. DOI: 10.3390/ijms24098224.